tiprankstipranks
Damora Therapeutics (DMRA)
NASDAQ:DMRA
US Market
DMRA
Damora Therapeutics
RESEARCH TOOLSreports

Damora Therapeutics (DMRA) Financial Statements

326 Followers

Damora Therapeutics Financial Overview

Damora Therapeutics's market cap is currently $1.48B. The company's EPS TTM is $-3.243; its P/E ratio is -2.31; Damora Therapeutics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -181.00K$ -830.00K$ -490.00K$ -441.00K
Operating Income$ -210.87M$ -16.90M$ -36.46M$ -61.21M$ -52.23M
EBITDA$ -210.84M$ -16.72M$ -35.63M$ -60.72M$ -51.79M
Net Income$ -209.84M$ -21.44M$ -38.35M$ -61.62M$ -51.75M
Balance Sheet
Cash & Short-Term Investments$ 257.62M$ 14.18M$ 33.15M$ 60.22M$ 100.19M
Total Assets$ 260.53M$ 17.13M$ 38.23M$ 73.19M$ 122.22M
Total Debt$ 68.00K$ 1.43M$ 249.00K$ 804.00K$ 847.00K
Net Debt$ -257.56M$ -12.74M$ -21.22M$ -31.98M$ -61.72M
Total Liabilities$ 20.15M$ 2.66M$ 5.90M$ 11.44M$ 4.99M
Stockholders' Equity$ 240.38M$ 14.47M$ 32.33M$ 61.75M$ 117.22M
Cash Flow
Free Cash Flow$ -6.73M$ -18.62M$ -36.91M$ -43.13M$ -52.53M
Operating Cash Flow$ -6.73M$ -18.62M$ -36.91M$ -42.93M$ -52.31M
Investing Cash Flow$ -17.37M$ 11.65M$ 22.33M$ 12.38M$ -48.05M
Financing Cash Flow$ 266.84M$ 0.00$ 2.88M$ 507.00K$ 0.00
Currency in USD

Damora Therapeutics Earnings and Revenue History

Income Statement >

Damora Therapeutics Debt to Assets

Balance Sheet >

Damora Therapeutics Cash Flow

Cash Flow >

Damora Therapeutics Forecast EPS vs Actual EPS

Earnings >